Radiochemistry for positron emission tomography
Positron emission tomography (PET) constitutes a functional imaging technique that is
harnessed to probe biological processes in vivo. PET imaging has been used to diagnose …
harnessed to probe biological processes in vivo. PET imaging has been used to diagnose …
Updates in diagnosis, management, and treatment of neuroblastoma
CC Swift, MJ Eklund, JM Kraveka, AL Alazraki - Radiographics, 2018 - pubs.rsna.org
Neuroblastoma is an embryonic tumor of the peripheral sympathetic nervous system. It is the
most common extracranial solid tumor of childhood and accounts for up to 15% of all …
most common extracranial solid tumor of childhood and accounts for up to 15% of all …
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
JJ Zaknun, L Bodei, J Mueller-Brand, ME Pavel… - European journal of …, 2013 - Springer
Peptide receptor radionuclide therapy (PRRNT) is a molecularly targeted radiation therapy
involving the systemic administration of a radiolabelled peptide designed to target with high …
involving the systemic administration of a radiolabelled peptide designed to target with high …
Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA
MF Bozkurt, I Virgolini, S Balogova, M Beheshti… - European journal of …, 2017 - Springer
Abstract Purpose & Methods Neuroendocrine neoplasms are a heterogenous group of
tumours, for which nuclear medicine plays an important role in the diagnostic work-up as …
tumours, for which nuclear medicine plays an important role in the diagnostic work-up as …
Somatostatin Receptor Imaging with 68Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation
Gallium 68 (68Ga) 1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid (DOTA)–
octreotate (DOTATATE, GaTate) positron emission tomography (PET)/computed tomography …
octreotate (DOTATATE, GaTate) positron emission tomography (PET)/computed tomography …
Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and …
SM Sadowski, V Neychev, C Millo, J Shih… - Journal of Clinical …, 2016 - ascopubs.org
Purpose Gastro-entero-pancreatic neuroendocrine tumors (GEPNETs) are increasing in
incidence, and accurate staging is important for selecting the appropriate treatment. 68Ga …
incidence, and accurate staging is important for selecting the appropriate treatment. 68Ga …
ICRU REPORT 96, dosimetry-guided radiopharmaceutical therapy
The International Commission on Radiation Units and Measurements (ICRU), since its
inception in 1925, has had as its principal objective the development of internationally …
inception in 1925, has had as its principal objective the development of internationally …
Prospective of 68Ga-radiopharmaceutical development
I Velikyan - Theranostics, 2013 - pmc.ncbi.nlm.nih.gov
Positron Emission Tomography (PET) experienced accelerated development and has
become an established method for medical research and clinical routine diagnostics on …
become an established method for medical research and clinical routine diagnostics on …
Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study
L Bodei, M Cremonesi, CM Grana, N Fazio… - European journal of …, 2011 - Springer
Purpose Peptide receptor radionuclide therapy (PRRT) is used in tumours expressing type 2
somatostatin receptors (sst 2), mainly neuroendocrine. The aim of this prospective phase I-II …
somatostatin receptors (sst 2), mainly neuroendocrine. The aim of this prospective phase I-II …
Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT
OBJECTIVE. The purpose of this article is to provide a review of the use of 68Ga
tetraazacyclododecanetetraacetic acid–DPhe1-Tyr3-octreotate (DOTATATE) PET/CT, a …
tetraazacyclododecanetetraacetic acid–DPhe1-Tyr3-octreotate (DOTATATE) PET/CT, a …